Bayesian estimation of HIV acquisition dates for prevention trials.

Saved in:
Bibliographic Details
Title: Bayesian estimation of HIV acquisition dates for prevention trials.
Authors: Rossenkhan R; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA., Giorgi EE; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA., Shao D; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA., Ludwig J; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA., Labuschagne P; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA.; South African National Bioinformatics Institute, University of the Western Cape, South African Medical Research Council Bioinformatics Unit, Cape Town, South Africa., Magaret CA; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA., Ndung'u T; The Doris Duke Medical Research Institute, University of KwaZulu-Natal, HIV Pathogenesis Programme, Durban, South Africa.; Africa Health Research Institute, Durban, South Africa.; Division of Infection and Immunity, University College London, London, United Kingdom.; Ragon Institute of Massachusetts General, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA., Muema D; The Doris Duke Medical Research Institute, University of KwaZulu-Natal, HIV Pathogenesis Programme, Durban, South Africa.; Africa Health Research Institute, Durban, South Africa., Gounder K; The Doris Duke Medical Research Institute, University of KwaZulu-Natal, HIV Pathogenesis Programme, Durban, South Africa.; Africa Health Research Institute, Durban, South Africa., Dong KL; Ragon Institute of Massachusetts General, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA., Walker BD; The Doris Duke Medical Research Institute, University of KwaZulu-Natal, HIV Pathogenesis Programme, Durban, South Africa.; Ragon Institute of Massachusetts General, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA., Rolland M; Walter Reed Army Institute of Research, U.S. Military HIV Research Program, Silver Spring, Maryland, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA., Robb ML; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA., Eller LA; Walter Reed Army Institute of Research, U.S. Military HIV Research Program, Silver Spring, Maryland, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA., Sawe F; Henry M. Jackson Foundation Medical Research International, Nairobi, Kenya.; Kenya Medical Research Institute, U.S. Army Medical Research Directorate, Nairobi, Kenya., Nitayaphan S; Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand., Grebe E; Stellenbosch University, South African Centre for Epidemiological Modeling and Analysis (SACEMA), Stellenbosch, South Africa.; University of California at San Francisco, Laboratory Medicine, San Francisco, USA.; Vitalant Research Institute, San Francisco, California, USA., Busch MP; University of California at San Francisco, Laboratory Medicine, San Francisco, USA.; Vitalant Research Institute, San Francisco, California, USA., Delaney KP; National Center for HIV Viral Hepatitis, STD and TB Prevention, Division of HIV Prevention, Atlanta, Georgia, USA., Facente S; Vitalant Research Institute, San Francisco, California, USA.; Facente Consulting, Richmond, Virginia, USA.; University of California, Berkeley, School of Public Health, Berkeley, California, USA., Carpp LN; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA., deCamp AC; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA., Huang Y; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA., Korber B; New Mexico Consortium, Los Alamos, New Mexico, USA.; Los Alamos National Laboratory, Theoretical Division, Los Alamos, New Mexico, USA., Juraska M; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA., Rudnicki E; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA., Kosmider E; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA., Reeves DB; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA., Mayer BT; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA., Hural J; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA., Deng W; Department of Microbiology, University of Washington, Seattle, Washington, USA., Westfall DH; Department of Microbiology, University of Washington, Seattle, Washington, USA., Yssel A; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Matten D; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Bhattacharya T; New Mexico Consortium, Los Alamos, New Mexico, USA.; Santa Fe Institute, Santa Fe, New Mexico, USA., Corey L; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA.; Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA., Gilbert PB; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA.; Fred Hutchinson Cancer Center, Public Health Sciences Division, Seattle, Washington, USA.; Department of Biostatistics, University of Washington, Seattle, Washington, USA., Williamson C; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; Division of Medical Virology, Wellcome Centre for Infectious Diseases Research in Africa, Department of Pathology Faculty of Health Sciences and National Health Laboratory Service, University of Cape Town, Cape Town, South Africa., Mullins JI; Department of Global Health, University of Washington, Seattle, Washington, USA.; Department of Microbiology, University of Washington, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA., Edlefsen PT; Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, Washington, USA.
Source: MBio [mBio] 2025 Oct 08; Vol. 16 (10), pp. e0188125. Date of Electronic Publication: 2025 Sep 09.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101519231 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2150-7511 (Electronic) NLM ISO Abbreviation: mBio Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2150-7511
DOI:10.1128/mbio.01881-25